List of Publications Prof. Dr. Andreas Kirschning

Showing results 81 - 90 out of 321

2016


Gille, F., & Kirschning, A. (2016). Studies on the synthesis of peptides containing dehydrovaline and dehydroisoleucine based on copper-mediated enamide formation. Beilstein Journal of Organic Chemistry, 12, 564-570. https://doi.org/10.3762/bjoc.12.55
Hoepfner, J., Kleinsorge, M., Papp, O., Ackermann, M., Alfken, S., Rinas, U., Solodenko, W., Kirschning, A., Sgodda, M., & Cantz, T. (2016). Biphasic modulation of Wnt signaling supports efficient foregut endoderm formation from human pluripotent stem cells. Cell Biology International, 40(5), 534-548. https://doi.org/10.1002/cbin.10590
Hartwig, J., & Kirschning, A. (2016). Flow Synthesis in Hot Water: Synthesis of the Atypical Antipsychotic Iloperidone. Chemistry - A European Journal, 22(9), 3044-3052. https://doi.org/10.1002/chem.201504409
Busch, T., Dräger, G., Kunst, E., Benson, H., Sasse, F., Siems, K., & Kirschning, A. (2016). Synthesis and antiproliferative activity of new tonantzitlolone-derived diterpene derivatives. Organic and Biomolecular Chemistry, 14(38), 9040-9045. https://doi.org/10.1039/c6ob01697a
Müller, R., & Kirschning, A. (2016). Verbundprojekt: TTU 09.903 - Optimisation of the Cystobactamides, a novel class of broad spectrum antibiotics from myxobacteria: Bereich: DZIF TTU 9 “Neuartige Antiinfektiva”: Schlussbericht. Helmholtz-Zentrum für Infektionsforschung. https://doi.org/10.2314/GBV:876762097

2015


Bułyszko, I., Dräger, G., Klenge, A., & Kirschning, A. (2015). Evaluation of the Synthetic Potential of an AHBA Knockout Mutant of the Rifamycin Producer Amycolatopsis mediterranei. Chemistry - A European Journal, 21(52), 19231-19242. https://doi.org/10.1002/chem.201503548
Perin, P. M., Haid, S., Brown, R. J. P., Doerrbecker, J., Schulze, K., Zeilinger, C., von Schaewen, M., Heller, B., Vercauteren, K., Luxenburger, E., Baktash, Y. M., Vondran, F. W. R., Speerstra, S., Awadh, A., Mukhtarov, F., Schang, L. M., Kirschning, A., Müller, R., Guzman, C. A., ... Pietschmann, T. (2015). Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1. Hepatology, 63(1), 49-62. https://doi.org/10.1002/hep.28111
Hartwig, J., & Kirschning, A. (2015). Iterative Syntheses: The Gateway to New Automation Protocols. Angewandte Chemie , 54(36), 10412-10414. https://doi.org/10.1002/anie.201504615, https://doi.org/10.1002/ange.201504615
Müller, R., Hartmann, R. W., Kirschning, A., Weiss, S., Tegge, W., & Häussler, S. (2015). Biofilm-Inhibitoren: Entwicklung von Inhibitoren zur Prävention und Behandlung von Biofilmen humanpathogener Bakterien: Abschlussbericht: Laufzeit des Vorhabens: 01.02.2012-31.01.2015. Twincore Zentrum für Experimentelle und Klinische Infektionsforschung. https://edocs.tib.eu/files/e01fb16/857120247.pdf
Moreno, M., Elgaher, W. A. M., Herrmann, J., Schläger, N., Hamed, M. M., Baumann, S., Müller, R., Hartmann, R. W., & Kirschning, A. (2015). Synthesis and biological evaluation of cystobactamid 507: A bacterial topoisomerase inhibitor from Cystobacter sp. Synlett, 26(9), 1175-1178. Article st-2015-b0058-l. https://doi.org/10.1055/s-0034-1380509